The global prostate cancer diagnostics and therapy market was valued at USD 19,475.00 in 2018. The market studied is expected to register a growth rate of 8.63% over the forecast period. The primary drivers for the market studied include increasing prevalence of prostate cancer, increasing government initiatives to control the growing prevalence of prostate cancer, and improvements in genetics and genomics.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS